EMEA-001986-PIP01-16

Key facts

Invented name
Xofigo
Active substance
radium Ra223 dichloride
Therapeutic area
Oncology
Decision number
P/0178/2017
PIP number
EMEA-001986-PIP01-16
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
  • Treatment of Multiple Myeloma
  • Treatment of all conditions included in the category of malignant neoplasms (except central nervous system tumours, haematopoietic and lymphoid tissue neoplasms)
Route(s) of administration
Intravenous use
Contact for public enquiries
Bayer AG

Tel. +49 30300139003
E-mail: clinical-trials-contact@bayer.com

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating